Index of reports
> Cases with Interstitial Lung Disease (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Doxil (Doxorubicin) where reactions include interstitial lung disease. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Doxil side effects in 85 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30
Patient: 85 year old male, weighing 82.1 kg (180.6 pounds)
Reactions: Diabetes Mellitus, Oral Candidiasis, Interstitial Lung Disease, Acute Respiratory Distress Syndrome, Blood Creatinine Increased, Blood Urea Increased, Vomiting, Blood Chloride Decreased, Aortic Calcification, Atrial Fibrillation, Pancytopenia, Hyponatraemia, Mitral Valve Calcification, Brain Natriuretic Peptide Increased, Pernicious Anaemia, Dehydration, Mitral Valve Incompetence, Hypothyroidism, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 10 mg/daily/po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-01-31
End date: 2011-02-13
Decadron
Dosage: 40 mg/wky/
Indication: Multiple Myeloma
Start date: 2011-01-31
End date: 2011-02-10
Doxil
Dosage: 8 mg
Indication: Multiple Myeloma
Start date: 2011-01-31
End date: 2011-02-10
Velcade
Dosage: 2 mg
Indication: Multiple Myeloma
Start date: 2011-01-31
End date: 2011-02-13
Other drugs received by patient: Procrit; Aspirin; Neurontin; Zometa; Ciprofloxacin; Thioctic Acid; Synthroid; Dflucan; Calcium (Unspecified); Levoxyl; Acyclovir
Possible Doxil side effects in female
Reported by a physician from Japan on 2012-04-10
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Ovarian Cancer Recurrent, Interstitial Lung Disease
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxil
Dosage: cycle 1
Start date: 2009-06-12
End date: 2009-06-12
Doxil
Dosage: cycle 2
Start date: 2009-07-10
End date: 2009-07-10
Doxil
Dosage: cycle 4
Start date: 2009-09-04
End date: 2009-09-04
Doxil
Dosage: cycle 3
Indication: Ovarian Cancer Recurrent
Start date: 2009-08-07
End date: 2009-08-07
Other drugs received by patient: Decadron; Decadron; Gran; Daio-Kanzo-TO; Azunol; Decadron; Decadron; Sunrythm; Decadron; Thiamine Monophosphate Disulfide; Thiamine Monophosphate Disulfide; Meiact; Decadron; Decadron; Thiamine Monophosphate Disulfide; Gemcitabine Hydrochloride; Decadron; Ramelteon; Thiamine Monophosphate Disulfide; Zolpidem; Decadron; Decadron; Banan; Ramelteon; Ramelteon; Ramelteon
Possible Doxil side effects in female
Reported by a pharmacist from Japan on 2012-04-10
Patient: female, weighing 57.0 kg (125.4 pounds)
Reactions: Hepatic Function Abnormal, Restlessness, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Fatigue, Malaise, Cardiac Failure, Interstitial Lung Disease, Dehydration, Bone Marrow Failure, Blood Pressure Decreased, Decreased Appetite, Anuria, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Doxil
Start date: 2010-11-24
End date: 2010-11-24
Doxil
Start date: 2010-11-24
End date: 2010-11-24
Doxil
Indication: Malignant Peritoneal Neoplasm
Start date: 2010-12-22
End date: 2010-12-22
Doxil
Indication: Ovarian Cancer Recurrent
Start date: 2010-12-22
End date: 2010-12-22
Cisplatin W / Docetaxel
Indication: Malignant Peritoneal Neoplasm
Cyclophosphamide
Indication: Malignant Peritoneal Neoplasm
Zosyn
Indication: Interstitial Lung Disease
Start date: 2011-01-14
End date: 2011-02-06
Minocycline Hydrochloride
Indication: Infection
Start date: 2011-01-29
End date: 2011-01-31
Minocycline Hydrochloride
Indication: Pyrexia
Start date: 2011-01-29
End date: 2011-01-31
Taxotere
Indication: Malignant Peritoneal Neoplasm
Other drugs received by patient: Methycobal; Futhan; Recomodulin; Norvasc; Elaspol; Pentamidine Isethionate; Gosha-Jinki-GAN; Bactrim; Solu-Medrol; Zithromax; Predopa; Dalteparin Sodium; Reminaron; Bactrim; Solu-Medrol; Solu-Medrol; Mucosta; DAI-Kenchu-TO; Futhan; Dalteparin Sodium; Prodif; Humulin R; Magnesium Oxide; Midazolam HCL; Midazolam HCL; Vancomycin Hydrochloride; Pentamidine Isethionate; Predopa; Vancomycin Hydrochloride; Dalteparin Sodium; Prednisolone; Concentrated Human Blood Platelets
Possible Doxil side effects in female
Reported by a physician from Japan on 2012-04-10
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Ovarian Cancer Recurrent, Interstitial Lung Disease
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxil
Dosage: cycle 1
Start date: 2009-06-03
End date: 2009-06-03
Docetaxel
Dosage: 3 cycles completed
End date: 2009-03-01
Docetaxel
Dosage: 5 cycles completed
Indication: Ill-Defined Disorder
End date: 2008-11-13
Doxil
Dosage: cycle 2
Indication: Ovarian Cancer Recurrent
Start date: 2009-07-01
End date: 2009-07-01
Gemcitabine
Dosage: 3 cycles completed
Indication: Ill-Defined Disorder
End date: 2009-03-24
Other drugs received by patient: Decadron; Ramosetron Hydrochloride; Thiamine Monophosphate Disulfide; Decadron; Decadron; Astomin; Azunol
Possible Doxil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-23
Patient: male
Reactions: Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Start date: 2010-09-27
End date: 2011-07-01
Doxil
Indication: Product Used FOR Unknown Indication
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
End date: 2011-08-01
Decadron
Indication: Product Used FOR Unknown Indication
Velcade
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Lasix; Prednisone TAB; Coreg; Flonase; Zometa; Ondansetron; Potassium Chloride; Prochlorperazine; Protonix; Vicodin; Fluconazole; Lovenox; Mepron; Ativan; Gabapentin
Possible Doxil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-18
Patient: male
Reactions: Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
End date: 2011-08-01
Revlimid
Administration route: Oral
Start date: 2010-09-27
End date: 2011-07-01
Velcade
Indication: Product Used FOR Unknown Indication
Decadron
Indication: Product Used FOR Unknown Indication
Doxil
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Potassium Chloride; Ondansetron; Flonase; Gabapentin; Lovenox; Coreg; Ativan; Mepron; Prednisone TAB; Protonix; Lasix; Prochlorperazine; Vicodin; Fluconazole; Zometa
Possible Doxil side effects in female
Reported by a physician from Japan on 2011-10-28
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Interstitial Lung Disease, Ovarian Cancer
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Doxil
Dosage: cycle 1
Indication: Ovarian Cancer
Start date: 2010-06-29
End date: 2010-06-29
Doxil
Dosage: cycle 1
Indication: Malignant Ascites
Start date: 2010-06-29
End date: 2010-06-29
Other drugs received by patient: Aldactone; Lasix; Etodolac; Magmitt; Pursennid; Betamethasone
Possible Doxil side effects in 71 year old female
Reported by a physician from Japan on 2011-10-24
Patient: 71 year old female
Reactions: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxil
Dosage: cycle 2
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-09
End date: 2011-09-09
Doxil
Dosage: cycle 1
Start date: 2011-07-01
End date: 2011-07-01
Possible Doxil side effects in female
Reported by a physician from Japan on 2011-10-21
Patient: female
Reactions: Interstitial Lung Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxil
Possible Doxil side effects in female
Reported by a pharmacist from Japan on 2011-10-14
Patient: female, weighing 47.0 kg (103.4 pounds)
Reactions: Stomatitis, Nausea, Interstitial Lung Disease, Constipation, Ulcer, Blister
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Doxil
Dosage: cycle 1
Indication: Ovarian Cancer Recurrent
Start date: 2010-05-12
End date: 2010-05-12
Doxil
Dosage: cycle 4
Start date: 2011-03-01
End date: 2011-03-01
Doxil
Dosage: cycle 2
Doxil
Dosage: cycle 4
Start date: 2010-08-03
End date: 2010-08-03
Doxil
Dosage: cycle 3
Other drugs received by patient: Dexaltin; Oxycontin; Ramelteon; Dexaltin; Loxonin; Ramelteon; Orgadrone; Orgadrone; Etodolac
|